Romo v. Teva Pharmaceuticals USA, Inc.
742 F.3d 909, 2014 WL 505173
Court of Appeals for the Ninth Circuit·Decided February 10, 2014·No. Nos. 13-56310, 13-56306·Published·Cited by 5 cases
Opinion
ORDER
Upon the vote of a majority of nonre-cused active judges, it is ordered that these cases be reheard en banc pursuant to Federal Rule of Appellate Procedure 35(a) and Circuit Rule 35-3. The three-judge panel opinion in Romo v. Teva Pharmaceuticals USA, Inc., No. 13-56310, shall not be cited as precedent by or to any court of the Ninth Circuit.
Judge McKEOWN did not participate in the deliberations or vote in this case.
Free access — add to your briefcase to read the full text and ask questions with AI
Romo v. Teva Pharmaceuticals USA, Inc., 742 F.3d 909, 2014 WL 505173 (9th Cir. 2014).
742 F.3d 909 (Romo v. Teva Pharmaceuticals USA, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.
Related
Margalit Corber v. Xanodyne Pharmaceuticals, Inc.
771 F.3d 1218 (Ninth Circuit, 2014)
Teague v. Johnson & Johnson
749 F.3d 879 (Tenth Circuit, 2014)